RBC Europe’s Precigen PGEN Stock Holding History

RBC Europe’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-500	Closed	-$2.5K	–	996
2021 Q3	$2.5K	Hold	500	–	–	﹤0.01%	1105
2021 Q2	$3.26K	Hold	500	–	–	﹤0.01%	1083
2021 Q1	$3.44K	Hold	500	–	–	﹤0.01%	1022
2020 Q4	$5.1K	Hold	500	–	–	﹤0.01%	971
2020 Q3	$1.75K	Hold	500	–	–	﹤0.01%	999
2020 Q2	$2.5K	Hold	500	–	–	﹤0.01%	938
2020 Q1	$1.7K	Hold	500	–	–	﹤0.01%	929
2019 Q4	$2.74K	Hold	500	–	–	﹤0.01%	944
2019 Q3	$2.86K	Hold	500	–	–	﹤0.01%	939
2019 Q2	$3.83K	Hold	500	–	–	﹤0.01%	942
2019 Q1	$2.63K	Hold	500	–	–	﹤0.01%	979
2018 Q4	$3.27K	Hold	500	–	–	﹤0.01%	962
2018 Q3	$8.61K	Sell	500 -290	-37%	-$4.31K	﹤0.01%	878
2018 Q2	$11K	Hold	790	–	–	﹤0.01%	836
2018 Q1	$12.1K	Hold	790	–	–	﹤0.01%	791
2017 Q4	$9.1K	Buy	790 +250	+46%	+$3.72K	﹤0.01%	855
2017 Q3	$10.3K	Buy	+540	New	+$11.1K	﹤0.01%	826

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBC Europe's PGEN Position: Q4 2021 in Review

RBC Europe sold out of Precigen (PGEN) in Q4 2021, closing a stake of 500 shares — an estimated $2.5K sold.

RBC Europe first reported a position in PGEN in Q3 2017 and held it in 17 quarters. The position peaked at $12.1K in Q1 2018. 168 funds tracked by Wall St. Rank hold PGEN as of Q4 2021.

RBC Europe reported no remaining Precigen position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 500 Precigen shares in Q4 2021, an estimated $2.5K.
RBC Europe first reported a position in Precigen in Q3 2017 and held it in 17 quarters.
RBC Europe's Precigen position peaked at $12.1K in Q1 2018.
168 funds tracked by Wall St. Rank held Precigen as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.